Johnson & Johnson executive praises China's biotech innovation in oncology and immunology, highlighting potential future ...

The portfolio will comprise 20-25 B2B startups spanning Pre-seed to Series A stages, addressing innovation gaps in areas such as pharmaceuticals, biotechnology, medical technology, specialty chemicals ...

The IXP Lifesciences Catalyst Fund has a greenshoe option of Rs 100 crore with an investment horizon of 3-5 years targeting ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

A joint report by the Institute for Deep Tech Innovation (DEEP) at ESMT Berlin and the Bertelsmann Stiftung highlights Germany’s immense innovation potential in the biotech sector. However, this ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

Biotech Showcase™ 2025 Opens the Year with ... These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry. Plus, tired of market noise?

The fund aims to build a portfolio of 20-25 companies that address gaps in services and products across pharmaceuticals, ...

Biotech Showcase™ 2025 Opens the Year with More than 3,000 Attendees, 340+ Presenting Companies, 1,020+ Investors and 85+ Members of the Media ...